Anzeige
Mehr »
Freitag, 08.08.2025 - Börsentäglich über 12.000 News
Das Kupferangebot bricht ein - und dieser neue Fund kommt genau zur richtigen Zeit
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 932242 | ISIN: IE0005711209 | Ticker-Symbol: IJF
Tradegate
07.08.25 | 19:52
135,80 Euro
+0,22 % +0,30
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ICON PLC Chart 1 Jahr
5-Tage-Chart
ICON PLC 5-Tage-Chart
RealtimeGeldBriefZeit
135,15136,8012:43
135,15136,8012:34

Aktuelle News zur ICON Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
30.07.Hoth Therapeutics Engages ICON to Expand Clinical Trial for HT-0017
29.07.Hoth Therapeutics, Inc.: Hoth Therapeutics Announces Engagement with ICON and Expansion of Phase II Clinical Trial for HT-001 in Europe143The Company plans to extend its Phase II trial of HT-001 in Cancer Patients with skin toxicities in European Union (EU) Countries NEW YORK, July 29, 2025 /PRNewswire/...
► Artikel lesen
24.07.ICON Stock Up After Q2 Results Signal Growing Confidence In Biopharma Recovery5
23.07.ICON Plc Q2 Profit Climbs10
23.07.ICON PLC - 6-K, Report of foreign issuer1
ICON Aktie jetzt für 0€ handeln
23.07.ICON plc: ICON Announces Results of Annual General Meeting215ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation powered by healthcare intelligence, today announced that all resolutions at the Annual General Meeting of the company (AGM)...
► Artikel lesen
23.07.ICON plc: ICON Reports Second Quarter 2025 Results262Highlights Gross business wins in the quarter of $2,966 million, representing an increase of 10.6% on quarter one 2025. Net business wins in the quarter of $2,057 million; a net book...
► Artikel lesen
16.07.ICON plc: ICON's Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report559ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research organisations (CRO) for phase 1...
► Artikel lesen
15.07.Do You Believe in the Upside Potential of ICON PLC (ICLR)?23
09.07.ICON plc stock price target lowered to $187 at Truist Securities6
07.07.ICON plc: ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability311ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2025 with a number of business awards, recognising the...
► Artikel lesen
26.06.Should You Hold ICON PLC (ICLR)?16
23.06.ICON plc Schedules Second Quarter 2025 Earnings Conference Call 281ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that it will release its financial results for the second quarter 2025...
► Artikel lesen
18.06.ICON PLC - 6-K, Report of foreign issuer1
11.06.ICON PLC - 6-K, Report of foreign issuer2
02.06.Here's Why You Should Retain ICLR Stock in Your Portfolio Now19
27.05.ICON plc wird auf der jährlichen Growth Stock Konferenz präsentieren10
27.05.ICON plc to Present at the William Blair 45th Annual Growth Stock Conference312ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the William Blair...
► Artikel lesen
27.05.ICON PLC - 6-K, Report of foreign issuer4
19.05.ICON PLC - 6-K, Report of foreign issuer1
Weiter >>
57 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1